Tobramycin Sulfate
Injection, USP
| General Information:Antibiotics |
| |
|
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Hospira |
Tobramycin |
40 mg/ mL |
00409-3590-02 |
PI |
MSDS |
|
|
|
20mg (10 mg/mL)
2 mL FTV
(pediatric)
|
00409-3577-01 |
PI |
MSDS |
|
|
|
80 mg
IN 0.9% Sodium
CL INJ 100mL |
00409-3470-23 |
PI |
MSDS |
|
Pfizer |
Tobramycin |
40mg/ml 2mL |
00069-0088-02 |
PI |
MSDS |
|
|
Tobramycin |
40mg/mL 30mL |
00069-0091-03 |
PI |
MSDS |
|
| |
|
| Clinical Data:
For any questions or for further information related to Tobramycin,
clinical pharmacology, additional indications and usages,
contraindications, warnings, precautions, adverse reactions, dosage,
administration and/or storage of this product, please
contact BDI Pharma or
call 1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|